TPA and BrdU promote CD133 expression in nasopharyngeal carcinoma cells
10.3781/j.issn.1000-7431.2010.02.003
- VernacularTitle:佛波醇脂和溴脱氧尿嘧啶核苷促进鼻咽癌细胞中CD133的表达
- Author:
Qingping JIANG
;
Weiyi FANG
;
Kaitai YAO
- Publication Type:Journal Article
- Keywords:
Nasopharyngeal neoplasms;
Phorbol esters;
Bromodeoxyuridine;
CD133
- From:
Tumor
2010;(2):100-104
- CountryChina
- Language:Chinese
-
Abstract:
Objective:To explore whether tumor-inducing agent 12-O-tetradecanoyl-phorbol-13-acetate (TPA) and bromodeoxyuridine (BrdU) affect CD133 expression in nasopharyngeal carcinoma (NPC) 5-8F cells. Methods:NPC cell line 5-8F was treated with single TPA, single BrdU, or TPA plus BrdU, respectively. CD133 mRNA and protein expression levels were detected by real-time fluorogentic quantitative PCR and Western blotting, respectively. Flow cytometry was used to separate CD133-positive cells and determine their levels. Boyden chamber test was used to measure the invasion capability of the cells. Results:Compared with untreated group, CD133 mRNA levels were increased in single BrdU group and BrdU plus TPA group (P=0.037 and 0.003, respectively), and decreased in single TPA group. Western blotting indicated that the expressions of CD133 protein was increased in all the three treated groups, and FCM showed that the quantity of CD133-positive cells also increased. The invasion capability was enhanced, especially in BrdU plus TPA group. Conclusion:Both TPA and BrdU increased CD133 expression in NPC.The effects of TPA and BrdU are synergestic.
